BioPharmSignal logoBioPharmSignal

Biotech News

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

Embecta (EMBC)EmbectaConference / presentation

PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.

Related news

MLYSMineralys Therapeutics2026-05-05 12:00 EST

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

SGMTSagimet Biosciences2026-08-04 11:00 EST

Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

MLYSMineralys Therapeutics2026-06-08 20:05 EST

Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

BLTEBelite Bio2026-07-15 12:00 EST

Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

BLTEBelite Bio2026-06-02 12:00 EST

Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

SGMTSagimet Biosciences2026-05-13 11:00 EST

Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

VANIVivani Medical2026-07-14 20:03 EST

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

LXRXLexicon Pharmaceuticals2026-05-28 12:30 EST

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

View all latest news

Embecta

Global Diabetes Care Embecta is a global diabetes-care company built on a nearly century-long history in insulin delivery. Its products are used by people who self-administer injectable therapies and by healthcare systems supporting diabetes management. Injection-Device Portfolio The company's core portfolio includes pen needles and...

Recent company news

EMBCEmbecta2026-08-07 10:30 EST

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

EMBCEmbecta2026-08-07 10:00 EST

embecta Announces Quarterly Cash Dividend

EMBCEmbecta2026-07-23 21:00 EST

embecta to Report Fiscal Third Quarter Financial Results

EMBCEmbecta2026-06-16 10:30 EST

embecta appoints Nimish Muzumdar as SVP and President, North America

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

Stock data

Close
3.50 USD
Market cap
207.05M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States